“…Bax can be activated by pro apoptotic stimuli or p53 and expression can be altered following radiation and is associated with resistance to chemotherapy (Miguel, Wajsenzon et al 2007), (Przemeck, Duckworth et al 2007), (Murphy, Mabruk et al 2002), (Johnson, Xiang et al 1998;Butt, Firth et al 2000), (Strobel, Swanson et al 1997), (Khanna, Wie et al 1996). This is in contrast to overexpression of bcl2 is associated with chemotherapy resistance and protects cells from radiation induced apoptosis (Hahn, Lai et al 2003), (Vrana, Grant et al 1999). 12 studies have assessed these proteins, 8 for Bcl2 expression and 4 have evaluated Bax expression as predictive markers (Qiu, Sirivongs et al 2000), (Rodel, Grabenbauer et al 2002), (Rodel, Hoffmann et al 2002), (Scott, Hale et al 1998), (Okonkwo, Musunuri et al 2001).…”